Nuevo fármaco contra la COVID protege a las personas con sistemas inmunitarios débiles de todas las variantes
VIERNES, 28 de abril de 2023 (HealthDay News) — Un nuevo medicamento de anticuerpos para ayudar a las personas inmunocomprometidas a luchar contra la infección con la COVID-19 podría estar disponible a finales de año. AstraZeneca anunció el jueves qu…
Learn MoreCardiovascular Complications From COVID-19 Rose as Pandemic Wore On
MONDAY, May 1, 2023 (HealthDay News) — Cardiovascular complications from COVID-19 rose among hospitalized patients from March 2020 to December 2021, according to a study published online April 5 in in Circulation: Cardiovascular Quality and Outcomes….
Learn MoreCould Long COVID Change Brain Activity?
MONDAY, May 1, 2023 (HealthDay News) — Scientists report that brain scans of long COVID patients show abnormal activity in areas related to memory.The scan results validate the concerns of these patients, who feel like they’re experiencing fatigue, t…
Learn More‘Long Road Back’: He Struggles With a Lung Condition Years After Severe COVID
MONDAY, May 1, 2023 (HealthDay News) — Hito Bazan never knew how much he’d appreciate every breath he takes until one day he couldn’t do it.The Houston police officer awoke one morning not able to eat, walk, talk or even breathe after three months in…
Learn MoreStruggles With COVID Left Many Americans With Medical Debt
MONDAY, May 1, 2023 (HealthDay News) — While COVID-19’s toll on health and wellness has been obvious, the virus has also hit people in the wallet.A new study links surviving COVID to financial challenges later, especially for folks who were hospitali…
Learn MoreNew COVID-19 Drug Guards Against All Variants in Immunocompromised
FRIDAY, April 28, 2023 (HealthDay News) — A new antibody drug to help fight COVID-19 infection in immunocompromised people may be available by the end of the year.AstraZeneca said Thursday that its treatment, called AZD3152, appears to work in all va…
Learn MoreCDC Relaxes COVID-19 Vaccination Rules for Foreign Travelers
FRIDAY, April 28, 2023 (HealthDay News) — Travelers to the United States will now only need a single bivalent COVID-19 vaccine from either Pfizer or Moderna to enter the country, the U.S. Centers for Disease Control and Prevention announced Thursday….
Learn MoreNew COVID Drug Guards Against All Variants in People With Weak Immune Systems
FRIDAY, April 28, 2023 (HealthDay News) — A new antibody drug to help fight COVID-19 infection in immune-compromised people may be available by the end of the year. AstraZeneca said Thursday that its treatment, called AZD3152, appears to work in all …
Learn MoreMortality High for Patients With Concurrent TB, COVID-19
FRIDAY, April 28, 2023 (HealthDay News) — Patients with concurrent tuberculosis (TB) and COVID-19 have a high risk for death, according to a study published online April 26 in PLOS Global Public Health.Alice V. Easton, Ph.D., from the New York City D…
Learn MoreCDC Relaxes COVID Vaccination Rules for Foreign Travelers
FRIDAY, April 28, 2023 (HealthDay News) — Travelers to the United States will now only need a single bivalent COVID vaccine from either Pfizer or Moderna to enter the country, the U.S. Centers for Disease Control and Prevention announced Thursday.The…
Learn More